Immune-related gene expression signatures can predict pathologic complete response and could be used to help decide which HER2 therapies to use for which patients, say researchers.
Dana-Farber researchers to present findings at San Antonio Breast Cancer Symposium 3 December miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.
Study finds breast cancers with low levels of HER2 protein are not distinct subtype of disease miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.
In an online poll over use of chemotherapy for premenopausal patients with early breast cancer, votes were split without consensus; debate on this issue continues.